Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SQI Diagnostics Inc V.SQD.H

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

Bullboard Posts
Comment by splurgeon Aug 30, 2020 11:01am
75 Views
Post# 31476609

RE:SQI has a direct-to-consumer Celiac Disease and Rheumatoid A

RE:SQI has a direct-to-consumer Celiac Disease and Rheumatoid AWe are going to need a lot of revenues guys.
They have 305 mln shares o/s. That is a lot. The board and private investors have funded the company and have issued 190 mln warrants and options an these expire all the way out to 2025 and allow for the purchase of shares most well below the current market value. That could mean almost 500 mln shares potentially o/s and that is before commerciallizing any of their products. These are non brokered private placements which is offerred to only a select few.

Yes they have many exciting products but keep in mind when one says "the test will be 98% accurate" is not the same as saying "the test is 98% accurate". Some of these products are still in developmental stages. Still early days but a lot of shares have been issued to get this fat on top of the debentures still o/s.
This is one of my concerns going forward from this level of share price but of course I also never thought Tesla would be trading at these crazy price levels.
splurge
Bullboard Posts